Alex Zhavoronkov (Insilico)

Weeks af­ter launch, Alex Zha­voronkov's AI-in­spired longevi­ty spin­out sells to Hong Kong-list­ed group

When Alex Zha­voronkov un­veiled In­sil­i­co’s longevi­ty-fo­cused spin­out, he kept the pre­cise amount of Se­ries A fund­ing un­der wraps — dis­clos­ing on­ly that it’s in the “few mil­lion” dol­lar range — but had its mar­quee syn­di­cate on full dis­play.

Hu­man Longevi­ty, a col­lab­o­ra­tor, co-led the round with ETP Ven­tures and Per­for­mance Im­pact Ven­ture Fund, flanked by BOLD Cap­i­tal Part­ners, Longevi­ty Vi­sion Fund, Ocu­lus co-founder Michael Antonov through Formic Ven­tures and LongeVC.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.